On this page
What is Molluscum Contagiosum?
Molluscum contagiosum is a common viral skin infection caused by the Molluscum contagiosum virus (MCV), a member of the Poxviridae family. The infection results in a benign skin condition characterized by small, distinctive raised bumps (papules) that can appear on virtually any part of the body.
It affects both children and adults. Transmission occurs through direct contact with infected skin or contaminated objects. In adults, lesions typically appear on the:
- Inner thighs
- Buttocks
- Groin
- Lower abdomen
In some cases, lesions may also involve the external genitalia and perianal area, which is why molluscum contagiosum is sometimes classified as a sexually transmitted infection (STI).
In children, lesions most commonly appear on the face, trunk, arms, and legs, although any area of the body can be affected.
While the infection poses no significant health risk and is self-limiting, it can be a source of physical discomfort and psychological distress, particularly for children who may feel embarrassed about visible bumps in school or sports environments.
Causes
Molluscum contagiosum is caused exclusively by the Molluscum contagiosum virus (MCV), a double-stranded DNA poxvirus with four known subtypes (MCV-1 through MCV-4), with MCV-1 being the most prevalent worldwide.
Anyone can contract this infection, but certain populations are at higher risk:
- Children between 1 and 10 years of age, particularly those in close contact with peers (school, nurseries, sports clubs)
- Individuals with a weakened immune system, including people living with HIV/AIDS, organ transplant recipients, and patients undergoing immunosuppressive therapy
- Patients with atopic dermatitis (eczema), as the compromised skin barrier facilitates viral entry
Transmission
The virus spreads through several routes:
- Direct skin-to-skin contact: touching an infected person’s lesions is the primary mode of transmission.
- Fomites (indirect contact through contaminated objects): towels, sponges, clothing, bed linen, and toys can all harbor the virus.
- Sexual contact: in adults, molluscum contagiosum is frequently transmitted through sexual activity, with lesions appearing in the genital and groin area.
- Autoinoculation: this is a particularly important route. Scratching or picking at an existing lesion and then touching another part of the body can spread the virus. Shaving over affected areas also poses a high risk, as razors act as fomites.
It is suspected that transmission may also occur in warm, moist shared environments such as swimming pools and saunas, though this route lacks definitive scientific confirmation. Current evidence suggests the virus is more likely spread through shared objects (pool toys, kickboards) than through the water itself.
It has been confirmed that the virus remains confined to the superficial layers of the skin and does not enter the bloodstream. This means molluscum contagiosum cannot be transmitted through coughing, sneezing, or blood-to-blood contact.
Unlike the viruses causing herpes simplex or herpes zoster, MCV does not establish latency. If lesions reappear after complete resolution, this indicates a new infection rather than viral reactivation.
The exact duration of contagiousness is not fully established; however, researchers believe the virus can be transmitted to others as long as visible lesions persist.
Symptoms
The incubation period typically ranges from 2 to 3 months, although scientific literature reports cases ranging from one week to six months.
The hallmark lesions of molluscum contagiosum, often colloquially referred to simply as “mollusca” (entirely unrelated to the marine molluscs of the animal kingdom), present as:
- Small, dome-shaped, raised papules
- White, pink, or flesh-colored
- With a characteristic central dimple (umbilication)
- Pearlescent appearance and smooth texture on palpation
- Diameter ranging from 2 to 5 mm (approximately the size of a pinhead to a pencil eraser)
Lesions tend to gradually enlarge over weeks. They can appear as single papules or in clusters. They are generally asymptomatic, though they may occasionally cause:
- Itching (pruritus)
- Redness and mild swelling
- Mild discomfort
They do not cause pain under normal circumstances. Lesions are extremely rare on the palms of the hands and soles of the feet.
In immunocompetent individuals, spontaneous resolution occurs within 6 to 18 months without scarring. In some cases, the infection may persist for up to 2 to 4 years.
In patients with AIDS or other forms of immunosuppression, lesions may be larger, more numerous, and more resistant to treatment, sometimes appearing on the face and neck, which is uncommon in immunocompetent hosts.
Risks and Complications
Molluscum contagiosum is generally a benign, self-limiting condition. Key points regarding risks include:
- No residual scarring in most cases, provided lesions are not traumatically removed or excessively scratched.
- No viral persistence: once resolved, the virus is completely cleared from the body. Unlike herpes viruses, MCV does not remain dormant. However, immunity is not acquired, meaning reinfection is possible upon re-exposure.
- Secondary bacterial infection: rare in immunocompetent patients, but a potential concern in HIV-positive individuals or those with severe eczema, where broken skin provides an entry point for bacteria.
- Psychological impact: particularly in children, visible lesions on exposed areas may lead to embarrassment, social withdrawal, or school-related distress, a consideration that often justifies active treatment even when medically it would not be strictly necessary.
Diagnosis
In the vast majority of cases, the diagnosis of molluscum contagiosum is clinical, made by a physician or dermatologist based solely on the visual characteristics of the lesions during physical examination.
Physical Examination and Dermoscopy
The pathognomonic feature (the finding that definitively identifies the disease) is the presence of the central umbilication on the pearlescent papule. This small central indentation, resembling a tiny navel, distinguishes molluscum from other skin lesions.
To improve diagnostic accuracy, especially in atypical cases, dermatologists frequently use dermoscopy (dermatoscopy), a non-invasive technique that uses polarized light and magnification to visualize subsurface skin structures. Under dermoscopy, molluscum lesions reveal:
- A white-yellow amorphous central area (the molluscum body)
- A surrounding vascular crown (crown vessels pattern)
This technique allows confident differentiation from conditions such as warts, keratosis, basal cell carcinoma, and other skin growths.
Further Diagnostic Tests
Laboratory testing is rarely required but may be indicated in atypical or unclear cases:
- Histological examination (biopsy): microscopic analysis of a papule reveals Henderson-Paterson bodies (large eosinophilic intracytoplasmic inclusions), confirming the viral diagnosis.
- PCR (Polymerase Chain Reaction): the central core material can be tested for MCV DNA. This is primarily used in research settings or highly complex clinical cases.
In adult patients presenting with numerous, large, or treatment-resistant lesions, clinicians may recommend immune system evaluation, including HIV testing, as extensive molluscum can be a marker of underlying immunodeficiency.
Treatment and Therapy
The primary goals of treatment are:
- Accelerate resolution of existing lesions
- Prevent autoinoculation (self-spreading to other body sites)
- Reduce the risk of transmission to others
Although lesions eventually resolve on their own, active treatment is increasingly recommended to shorten the disease course, reduce psychological distress, and minimize the window of contagiousness.
Treatment choices depend on patient age, lesion number and location, immune status, and patient/parent preference.
Watchful Waiting
In children with few lesions in non-friction areas, a watchful waiting strategy may be appropriate. The rationale is that the immune system will ultimately clear the virus without intervention or scarring.
However, this approach requires strict hygiene measures to prevent spreading the infection to siblings, classmates, or caregivers. It also requires regular follow-up to monitor for new lesion development.
This strategy is less suitable for patients with extensive lesions, lesions in sensitive or genital areas, atopic dermatitis, or immunosuppression.
Physical and In-Office Treatments
Physical removal methods are generally considered first-line treatments due to their immediate effectiveness. They may be mildly uncomfortable or painful, particularly in young children:
- Curettage: the lesion is manually scraped out using a curette (a small, spoon-shaped surgical instrument). It is highly effective and fast, but typically requires the prior application of a topical anesthetic cream (e.g., EMLA) for patient comfort.
- Cryotherapy: liquid nitrogen is applied to the lesion, freezing it. The papule sloughs off over the following days. Multiple sessions may be required. It can cause temporary discomfort and blistering.
- Laser therapy: pulsed dye laser (PDL) is used in selected or resistant cases. It offers rapid removal with a low risk of scarring and may be preferred for cosmetically sensitive areas.
- Electrocautery: high-frequency electrical current is used to destroy the lesion. Used less frequently due to a slightly higher scarring risk.
Topical Therapies
Topical treatments work by inducing a controlled local inflammatory response or directly interfering with viral replication. They are less immediately effective than physical removal but are preferred in very young children or in cases with many small lesions:
- Potassium hydroxide (KOH): available in various concentrations (5–20%), it dissolves the lesion and stimulates an immune response. Applied at home by parents under medical guidance.
- Salicylic acid and glycolic acid: keratolytic agents that gradually break down the papule layers. Available in various over-the-counter preparations.
- Cantharidin: a vesicant agent derived from blister beetles, applied in-office by the physician. It is painless at application (making it well tolerated by children) but causes a small blister within 24–48 hours that removes the lesion. Not currently FDA-approved in the United States but widely used in clinical practice.
- Imiquimod (5%): a topical immune response modifier that stimulates local innate and adaptive immunity. More commonly used in adults or in persistent/extensive cases. Evidence of efficacy in molluscum is moderate.
- Tretinoin: a topical retinoid occasionally used to thin the lesion surface and improve the penetration of other agents.
Note on Gentalyn Beta (betamethasone + gentamicin): This topical corticosteroid-antibiotic combination has no role in the treatment of molluscum contagiosum and should not be used for this condition.
Lifestyle and Home Management
Behavioral and hygiene measures are critical components of management, regardless of which treatment is chosen:
- Do not squeeze, scratch, or pop lesions: breaking a papule releases millions of viral particles, dramatically increasing the risk of autoinoculation and spreading to others. Broken lesions may also leave scars.
- Keep skin well moisturized: especially in patients with atopic dermatitis. An intact, well-hydrated skin barrier is the first line of defense against viral spread.
- Cover lesions with clothing, bandages, or waterproof dressings, particularly during sports, swimming, or sexual activity.
- Avoid shaving over affected areas, as razors act as fomites and spread the virus.
Prevention
Prevention of molluscum contagiosum relies on consistent hygiene and behavioral precautions:
- Wash hands frequently and thoroughly: handwashing is the single most effective measure against most infectious diseases, including molluscum.
- Avoid touching or scratching lesions, whether your own or those of an infected person. Direct contact with papules carries a high risk of (auto)inoculation.
- Cover lesions with clothing, bandages, or waterproof plasters to prevent accidental contact with others, especially in shared spaces (pools, locker rooms, schools).
- Use protection during sexual activity: if lesions are present in the genital or inguinal area, friction during intercourse can damage papules, releasing viral particles. Use of barrier contraception (condoms) reduces but does not eliminate risk, as lesions may be in areas not covered.
- Do not share personal items: towels, soap, sponges, bed linen, and clothing should not be shared, as these can act as fomites.
- Avoid shaving affected skin areas.
- If lesions are present on the genitals, abstain from sexual activity and consult a dermatologist promptly.
Frequently Asked Questions
What is molluscum contagiosum?
Molluscum contagiosum is a common viral skin infection caused by the Molluscum contagiosum virus (MCV), a poxvirus. It produces small, raised, flesh-colored or pearlescent bumps with a characteristic central dimple. It is particularly common in children (spread through play) and in sexually active adults.
How is it transmitted?
Transmission occurs primarily through direct skin-to-skin contact with an infected person’s lesions, through play in children and sexual contact in adults. It can also spread via contaminated objects (towels, clothing, toys) and through autoinoculation (touching a lesion then touching another body part).
How are molluscum lesions removed?
Removal should always be performed or supervised by a dermatologist. Options include physical removal (curettage, cryotherapy, laser) and topical treatments (potassium hydroxide, cantharidin, imiquimod). Importantly, molluscum is a self-limiting disease that will resolve spontaneously, treatment is recommended to shorten the course and prevent spread, not because it is medically urgent in otherwise healthy individuals.
How long does the infection last?
Without treatment, molluscum contagiosum typically resolves spontaneously within 6 to 18 months in immunocompetent individuals. In some cases, particularly in children with eczema or adults with immune compromise, it may persist for up to 4 years. Treatment does not necessarily eradicate the virus faster, but it reduces the number of lesions and lowers the risk of transmission.
Is Gentalyn Beta effective for molluscum contagiosum?
No. Gentalyn Beta is a combination of betamethasone (a corticosteroid) and gentamicin (an antibiotic). Neither component has antiviral activity against MCV, and topical corticosteroids could theoretically worsen the infection by suppressing local immune responses.
What are the most effective treatments for molluscum contagiosum?
The most effective treatments include curettage (physical removal with a curette), cryotherapy (liquid nitrogen), and physician-applied cantharidin. Topical agents such as imiquimod or potassium hydroxide are used for home management under medical guidance. The best approach depends on the patient’s age, the number and location of lesions, and individual clinical circumstances. A dermatologist consultation is essential.
Can molluscum contagiosum come back after treatment?
Yes. Treatment removes existing lesions but does not confer immunity against the virus. If re-exposed to MCV, a new infection can develop. In some patients, not all lesions may be treated in a single session, and new ones may appear during the course of treatment, requiring periodic follow-up visits.
Can molluscum contagiosum be spread through physical contact?
Yes. Direct contact with infected skin is the primary transmission route. Indirect contact through shared objects (towels, bedding, sponges) is also possible. To reduce the risk of spreading, avoid direct contact with lesions, do not share personal hygiene items, and cover lesions when in contact with others.
When is a person considered fully recovered?
A person can be considered fully recovered when all papules have completely disappeared and no new lesions appear over a sustained period of several months. Since there is no viral latency (unlike herpes), resolution of all visible lesions generally indicates clearance of the infection. However, periodic follow-up with a dermatologist is advisable, especially in immunocompromised patients, to confirm complete resolution and monitor for reinfection.
Bibliography and Sources
- Centers for Disease Control and Prevention (CDC). Molluscum Contagiosum. https://www.cdc.gov/molluscum-contagiosum/about/index.html
- CDC. Molluscum Contagiosum in Special Environments. https://www.cdc.gov/molluscum-contagiosum/special-environments/index.html
- Leung AKC, Lam JM, Leong KF. Molluscum Contagiosum: An Update. Recent Patents on Inflammation & Allergy Drug Discovery. 2020;14(1):56–68.
- Olsen JR, Gallacher J, Piguet V, Francis NA. Epidemiology of molluscum contagiosum in children: a systematic review. Family Practice. 2014;31(2):130–136.
- van der Wouden JC, van der Sande R, Kruithof EJ, et al. Interventions for cutaneous molluscum contagiosum. Cochrane Database of Systematic Reviews. 2017;5:CD004767.
- Dohil MA, Lin P, Lee J, Lucky AW, Paller AS, Eichenfield LF. The epidemiology of molluscum contagiosum in children. Journal of the American Academy of Dermatology. 2006;54(1):47–54.
- Berger EM, Orlow SJ, Patel RR, Schaffer JV. Experience with molluscum contagiosum and associated inflammatory reactions in a pediatric dermatology practice. Archives of Dermatology. 2012;148(11):1257–1264.
